Santa Rita do Sapucaí, Brazil – Quoretech, a rapidly growing cardiovascular diagnostic intelligence company, has established a significant presence in Santa Rita do Sapucaí, Minas Gerais, Brazil, becoming a major employer and innovator in the region. The company’s success is not only impacting the local economy but likewise transforming arrhythmia detection across Brazil and beyond, offering a more accessible and affordable solution to a critical healthcare challenge. This expansion reflects a broader trend of Brazilian companies leading the way in medical technology and innovation, particularly in addressing healthcare disparities.
Founded with the mission of making arrhythmia diagnosis accessible to everyone, Quoretech addresses a global problem: the estimated 100 million arrhythmia tests missed annually due to limited access to devices and specialists and the high costs associated with traditional diagnostic methods. Quoretech’s solution, QuoreOne, is a continuous monitoring system designed to improve diagnostic yield and provide affordable access to advanced cardiovascular diagnostics.
A Growing Hub for Innovation in Santa Rita do Sapucaí
Santa Rita do Sapucaí, a city known as the “Silicon Valley” of Brazil due to its concentration of technology companies, provides a fertile ground for Quoretech’s growth. The city’s strong engineering talent pool and supportive ecosystem have been instrumental in the company’s development. Quoretech’s location on Rua Josino Vilela, 300, Boa Vista, underscores its commitment to the region and its role in fostering local economic development. The company’s headquarters are also located in Wilmington, Delaware, USA, demonstrating its international ambitions.
According to Quoretech, their diagnostic rate for severe arrhythmias is 1.6 times higher than traditional methods. This improvement is achieved through continuous monitoring for up to seven days, utilizing three online leads, wireless technology, and rechargeable devices. The company’s commitment to affordability is also a key differentiator, making advanced cardiovascular diagnostics available in offices, clinics, and hospitals across Brazil.
Milestones and Expansion in Brazil
Quoretech’s growth trajectory has been remarkable. As of mid-2025, the company had already interpreted over 8.6 billion heartbeats through more than 100,000 diagnostic tests. They’ve also surpassed 800 customers, and their diagnostic services are now available in every state in Brazil. This widespread availability is a testament to their strategic partnerships and commitment to reaching underserved communities.
A particularly significant partnership with Grupo Fleury has seen Quoretech’s solution integrated across all of Fleury’s units, earning the company the Fleury Innovation Prize. Their collaboration with Hypera, while concluding in June 2025, played a crucial role in expanding access to arrhythmia diagnostics throughout the country. LinkedIn reports that Quoretech reached break-even in June 2025, a significant milestone while simultaneously scaling operations and preparing for international expansion.
QuoreOne: Technology and Accessibility
QuoreOne is designed to be user-friendly and accessible. The device is light, flexible, wireless, water-resistant, and features online data transmission. Analysis is supported by validated algorithms, ensuring accuracy and reliability. The company states that one in ten clinics in Brazil already use QuoreOne, demonstrating its growing adoption and impact on the healthcare landscape.
Cristina Pedrassi, Administrator at Lapacor, highlighted the positive impact of QuoreOne, stating that the clinic increased Holter exam capacity by 40% and reduced installation time by 20% within three months of operation. This feedback underscores the practical benefits of Quoretech’s technology for healthcare providers.
Company Details and Contact Information
Quoretech Brasil Industria e Comercio Ltda is registered in Santa Rita do Sapucaí, Minas Gerais. Dun & Bradstreet provides company research and financial data. For contact information, Quoretech can be reached at [email protected]. Their head office is located at 200 Bellevue Parkway, Suite 210, Wilmington, DE 19809, USA, with a Brazilian office at Rua Josino Vilela, 300, Boa Vista, 37538-636, Santa Rita do Sapucaí, MG, Brazil. The US head office phone number is +1 206-627-0030, and the São Paulo, Brazil number is +55 11 97319-6913.
Quoretech’s success story exemplifies the potential of Brazilian innovation to address global healthcare challenges. The company’s commitment to accessibility, affordability, and technological advancement positions it as a key player in the future of cardiovascular diagnostics. The next step for Quoretech involves continued international expansion, building on its strong foundation in Brazil and bringing its life-saving technology to more patients worldwide.
What are your thoughts on the role of technology in improving healthcare access? Share your comments below, and please share this article with your network.
